Our approach to the diagnosis and treatment of polymyalgia rheumatica and giant cell (temporal) arteritis

We believe there is a strong case for formalised collaborative care between GPs andĀ  rheumatologists in the management of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA), which can be difficult conditions to diagnose and manage. Our rapid access diagnostic care pathways allow early referral of patients who appear to have PMR or GCA, beforeĀ  glucocorticoids are prescribed.